These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7731958)

  • 1. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
    Boger DL; Johnson DS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
    Boger DL; Johnson DS; Yun W; Tarby CM
    Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
    Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
    J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
    Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
    Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a pronounced effect of noncovalent binding selectivity on the (+)-CC-1065 DNA alkylation and identification of the pharmacophore of the alkylation subunit.
    Boger DL; Zarrinmayeh H; Munk SA; Kitos PA; Suntornwat O
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1431-5. PubMed ID: 1847523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-selective guanine reactivity by duocarmycin A.
    Mitchell MA; Weiland KL; Aristoff PA; Johnson PD; Dooley TP
    Chem Res Toxicol; 1993; 6(4):421-4. PubMed ID: 8374036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation.
    Boger DL; Yun W; Han N
    Bioorg Med Chem; 1995 Nov; 3(11):1429-53. PubMed ID: 8634824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer.
    Tichenor MS; Trzupek JD; Kastrinsky DB; Shiga F; Hwang I; Boger DL
    J Am Chem Soc; 2006 Dec; 128(49):15683-96. PubMed ID: 17147378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a common molecular basis for sequence recognition of N3-guanine and N3-adenine DNA adducts involving the covalent bonding reaction of (+)-CC-1065.
    Park HJ
    Arch Pharm Res; 2002 Feb; 25(1):11-24. PubMed ID: 11885687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin.
    Trzupek JD; Gottesfeld JM; Boger DL
    Nat Chem Biol; 2006 Feb; 2(2):79-82. PubMed ID: 16415862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis for in situ activation of DNA alkylation by duocarmycin SA.
    Smith JA; Bifulco G; Case DA; Boger DL; Gomez-Paloma L; Chazin WJ
    J Mol Biol; 2000 Jul; 300(5):1195-204. PubMed ID: 10903864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective metal cation activation of a DNA alkylating agent: synthesis and evaluation of methyl 1,2,9, 9a-Tetrahydrocyclopropa[c]pyrido[3,2-e]indol-4-one-7-carboxylate (CPyI).
    Boger DL; Boyce CW
    J Org Chem; 2000 Jun; 65(13):4088-100. PubMed ID: 10866626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBI-CDPBO1 and CBI-CDPBI1: CC-1065 analogs containing deep-seated modifications in the DNA binding subunit.
    Boger DL; Yun W; Cai H; Han N
    Bioorg Med Chem; 1995 Jun; 3(6):761-7. PubMed ID: 7582954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA.
    Lee CS; Sun D; Kizu R; Hurley LH
    Chem Res Toxicol; 1991; 4(2):203-13. PubMed ID: 1782349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
    Boger DL; Hughes TV; Hedrick MP
    J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
    Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
    J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA sequence selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145.
    Kiakos K; Sato A; Asao T; McHugh PJ; Lee M; Hartley JA
    Mol Cancer Ther; 2007 Oct; 6(10):2708-18. PubMed ID: 17938264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+)-CC-1065 as a structural probe of Mu transposase-induced bending of DNA: overcoming limitations of hydroxyl-radical footprinting.
    Ding ZM; Harshey RM; Hurley LH
    Nucleic Acids Res; 1993 Sep; 21(18):4281-7. PubMed ID: 8414983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CC-1065 CBI analogs: an example of enhancement of DNA alkylation efficiency through introduction of stabilizing electrostatic interactions.
    Boger DL; Yun W; Han N; Johnson DS
    Bioorg Med Chem; 1995 Jun; 3(6):611-21. PubMed ID: 7582940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
    Boger DL; Stauffer F; Hedrick MP
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.